Quarterly Financial Results, Plant Outages, Stock Price Movements, and Earnings Release Schedules - Analyst Notes on KMP, CF Industries, Lululemon, Tyson Foods and Nu Skin

NEW YORK, April 24, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Kinder Morgan Energy Partners LP (NYSE: KMP), CF Industries Holdings, Inc. (NYSE: CF), Lululemon Athletica Inc. (NASDAQ: LULU), Tyson Foods Inc. (NYSE: TSN) and Nu Skin Enterprises Inc. (NYSE: NUS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1545-100free.

--
Kinder Morgan Energy Partners LP Analyst Notes
On April 16, 2014, Kinder Morgan Energy Partners LP (KMP) reported financial results for Q1 2014. The Company registered a 37.2% YoY increase in revenue to $3.7 billion, while income at the operating level increased 19.0% YoY to $933 million. Net income for Q1 2014 declined to $754 million or $0.67 per share from $792 million or $0.97 per share in Q1 2013. In addition, the Board of Directors increased its quarterly cash distribution per common unit to $1.38 ($5.52 annualized) payable on May 15, 2014, to shareholders of record as of April 30, 2014. Looking ahead, KMP expects to declare cash distributions of at least $5.58 per unit for 2014. The full analyst notes on KMP are available to download free of charge at:

http://www.analystsreview.com/1545-KMP-24Apr2014.pdf

--
CF Industries Holdings, Inc. Analyst Notes
On April 21, 2014, CF Industries Holdings, Inc. (CF Industries) announced that its entire Woodward, Oklahoma, nitrogen complex has been shut down for repairs due to a problem in a boiler. The Company reported that all of the plants in the complex were safely shut down with no impact on personnel, the nearby community or the environment. CF Industries estimates that it will take around 6 to 8 weeks for the plant to get operational. The plant will execute the turnaround maintenance activities during the outage that had earlier been scheduled for June. The Woodward complex has an average annual production capacity for 480,000 tons of gross ammonia, 820,000 tons of UAN, and 25,000 tons of urea liquor. Additionally, the sales team of the Company is connecting with customers to work through product availability and delivery schedule implications. The full analyst notes on CF Industries are available to download free of charge at:

http://www.analystsreview.com/1545-CF-24Apr2014.pdf

--
Lululemon Athletica Inc. Analyst Notes
On April 21, 2014, stock of Lululemon Athletica Inc. (Lululemon Athletica) closed at $49.07, down by 5.11%. The stock opened at $51.70 and oscillated between $47.91 and $51.70 during the day. As much as 7.22 million shares exchanged hands during the session up from previous session which witnessed trading volume of 2.69 million shares. According to The Street, the fall of shares of Lulemon Athletica was due to the "Underperform" rating received by the Company from Sterne Agee, a brokerage firm. The full analyst notes on Lululemon are available to download free of charge at:

http://www.analystsreview.com/1545-LULU-24Apr2014.pdf

--
Tyson Foods Inc. Analyst Notes
On April 21, 2014, shares of Tyson Foods Inc. (Tyson Foods) ended at $43.03, up 0.89%, and in line with the broader index (NYSE Composite), which ended the session at 10,559.35, up 0.25%. Tyson Foods' stock opened at $42.74 and fluctuated in the range of $42.68 - $43.11. A total of 3.41 million shares traded during the session, which was more than the previous day trading volume of 2.07 million. In the past one month, Tyson foods' stock has gained 1.56%, largely in line with the NYSE Composite that has gained 1.61% during the same time period. The Company will host its Q2 FY 2014 earnings conference call on May 5, 2014 at 9 a.m. ET (8 a.m. CT). The full analyst notes on Tyson Foods are available to download free of charge at:

http://www.analystsreview.com/1545-TSN-24Apr2014.pdf

--
Nu Skin Enterprises Inc. Analyst Notes
On April 19, 2014, Nu Skin Enterprises, Inc. (Nu Skin) issued a press release updating the general public and investor community about its Chinese operations. Nu Skin China informed that the Company is planning to resume corporate-hosted business meetings and will be accepting applications for new sales individuals on May 1, 2014. Dan Chard, President Global Sales and Operations, said, "China is an important marketplace for Nu Skin and we are committed to operating in full compliance with China's direct selling regulations to promote long-term success." Moreover, Nu Skin will report Q1 2014 financial results before the market opens on May 6, 2014 and will host a conference call at 11 a.m. EDT. The management is expected to provide an updated guidance and discuss upcoming business initiatives. The full analyst notes on Nu Skin are available to download free of charge at:

http://www.analystsreview.com/1545-NUS-24Apr2014.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

http://AnalystsReview.com

SOURCE Analysts Review